日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy

强 CD8+ 淋巴细胞浸润与 HLA I 类表达相结合与接受新辅助化疗的乳腺癌患者更好的肿瘤控制相关

A F de Groot, E J Blok, A Charehbili, C C Engels, V T H B M Smit, N G Dekker-Ensink, H Putter, E Meershoek-Klein Kranenbarg, C J H van de Velde, G J Liefers, J W R Nortier, P J K Kuppen, S H van der Burg, J R Kroep

The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis

Tregs 和肿瘤免疫亚型对接受辅助内分泌治疗的绝经后激素受体阳性乳腺癌患者的预后和预测价值:荷兰 TEAM 研究分析

C C Engels, A Charehbili, C J H van de Velde, E Bastiaannet, A Sajet, H Putter, E A van Vliet, R L P van Vlierberghe, V T H B M Smit, J M S Bartlett, C Seynaeve, G J Liefers, P J K Kuppen

Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma

乳腺癌的免疫亚型可预测浸润性导管癌,但不能预测浸润性小叶乳腺癌

C C Engels, D B Y Fontein, P J K Kuppen, E M de Kruijf, V T H B M Smit, J W R Nortier, G J Liefers, C J H van de Velde, E Bastiaannet